28 results
DEF 14A
ADPT
Adaptive Biotechnologies Corp
24 Apr 20
Definitive proxy
4:15pm
reputation or business, (5) the executive’s repeated failure or inability to perform any reasonable assigned duties after written notice
10-K
2019 FY
ADPT
Adaptive Biotechnologies Corp
26 Feb 20
Annual report
4:53pm
global portfolio of intellectual property rights to protect our immune medicine platform, the products and services that draw on it and our reputation … of these anti-bribery laws, or allegations of such violations, could have a negative impact on our business, results of operations and reputation. For instance
424B4
cj4202dx7a 5s8asa
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
jvllqv3 8nh
9 Jan 20
Draft registration statement
12:00am
10-Q
EX-10.12
amb5a9j 1gg4m85t4167
13 Aug 19
Quarterly report
4:36pm
8-K
EX-10.2
5577xf
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
5:29pm
424B4
zwryyqzv98shsx
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
EX-10.18
qls4tqxtht yozpbd
30 May 19
IPO registration
5:20pm
S-1
EX-10.12
oaknk2ng86m ngsrkig0
30 May 19
IPO registration
5:20pm
S-1
EX-10.11
x25266uvdn04u5
30 May 19
IPO registration
5:20pm
S-1
pzdm6k
30 May 19
IPO registration
5:20pm
S-1
EX-10.15
1rca0d ockc
30 May 19
IPO registration
5:20pm